Deerfield Private Design Fund II, L.P.
Insider CIK 1483687 · AVDL · ALIM 10% owner · DRNA 10% owner · TRIV 10% owner · ASPX 10% owner · NVLS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVDL AVADEL PHARMACEUTICALS PLC | S Sale | 2018-06-25 | 2018-06-25 | 114,034 | $5.99 | $683.1K | 952,265 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,530 | $3.04 | $83.7K | 728,718 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-08 | 2015-12-08 | 27,529 | $3.04 | $83.7K | 4,760,408 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 4,732,879 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-07 | 2015-12-08 | 68,294 | $3.00 | $204.9K | 701,188 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 632,894 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-04 | 2015-12-08 | 40,301 | $3.01 | $121.3K | 4,664,585 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,486 | $3.00 | $160.5K | 4,624,284 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-03 | 2015-12-03 | 53,487 | $3.00 | $160.5K | 592,593 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 539,106 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-02 | 2015-12-03 | 55,257 | $2.98 | $164.7K | 4,570,798 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,882 | $3.05 | $39.3K | 483,849 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-12-01 | 2015-12-03 | 12,883 | $3.05 | $39.3K | 4,515,541 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 470,967 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-11-06 | 2015-11-10 | 36,625 | $2.98 | $109.1K | 4,502,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 4,466,033 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-30 | 2015-11-03 | 8,271 | $3.00 | $24.8K | 434,342 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 426,071 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-28 | 2015-10-29 | 13,165 | $2.99 | $39.4K | 4,457,762 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 412,906 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-27 | 2015-10-29 | 16,506 | $3.00 | $49.5K | 4,444,597 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,117 | $3.00 | $51.4K | 396,400 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-26 | 2015-10-26 | 17,116 | $3.00 | $51.3K | 4,428,091 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,091 | $3.00 | $36.3K | 4,410,975 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-23 | 2015-10-26 | 12,090 | $3.00 | $36.3K | 379,283 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 4,398,884 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-22 | 2015-10-26 | 975 | $3.00 | $2.9K | 367,193 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 366,218 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-21 | 2015-10-21 | 80,342 | $3.00 | $241.0K | 4,397,909 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 4,317,567 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-20 | 2015-10-21 | 50,065 | $3.00 | $150.2K | 285,876 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 4,267,502 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-19 | 2015-10-21 | 64,613 | $2.92 | $188.7K | 235,811 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 171,198 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-09 | 2015-10-09 | 71,540 | $2.53 | $181.0K | 4,202,889 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,817 | $2.50 | $49.5K | 99,658 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-08 | 2015-10-09 | 19,816 | $2.50 | $49.5K | 4,131,349 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 79,841 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | P Buy | 2015-10-07 | 2015-10-09 | 69,536 | $2.30 | $159.9K | 4,111,533 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 2,013,613 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 869,667 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 1,401,003 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 1,085,085 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 1,243,423 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 385,962 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 54,385 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 85,962 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 817,541 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion deriv | 2015-06-23 | 2015-06-25 | 936,839 | — | $0 | 0 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 282,984 | — | $0 | 658,576 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 696,993 | — | $0 | 886,348 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 301,027 | — | $0 | 383,237 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 484,944 | — | $0 | 617,397 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 375,592 | — | $0 | 375,592 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 430,399 | — | $0 | 430,399 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 133,597 | — | $0 | 1,019,945 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 18,825 | — | $0 | 402,062 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 29,755 | — | $0 | 647,152 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | C Conversion | 2015-06-23 | 2015-06-25 | 324,278 | — | $0 | 754,677 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2015-06-23 | 2015-06-25 | 104,795 | $14.00 | $1.47M | 1,124,740 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2015-06-23 | 2015-06-25 | 67,666 | $14.00 | $947.3K | 726,242 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2015-06-23 | 2015-06-25 | 77,539 | $14.00 | $1.09M | 832,216 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 490,069 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 973,379 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 849,426 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 1,182,943 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 953,286 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2015-01-28 | 2015-01-28 | 167,760 | $56.50 | $9.48M | 849,426 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2015-01-28 | 2015-01-28 | 566,825 | $56.50 | $32.03M | 1,182,943 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2015-01-28 | 2015-01-28 | 192,240 | $56.50 | $10.86M | 973,379 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2015-01-28 | 2015-01-28 | 458,175 | $56.50 | $25.89M | 953,286 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2015-01-28 | 2015-01-28 | 115,000 | $56.50 | $6.50M | 490,069 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-25 | 2014-11-25 | 48,027 | $11.50 | $552.3K | 698,822 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-25 | 2014-11-25 | 55,035 | $11.50 | $632.9K | 800,794 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-25 | 2014-11-25 | 18,903 | $11.50 | $217.4K | 275,046 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 1,300 | $11.54 | $15.0K | 308,148 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 36,074 | $11.55 | $416.7K | 750,152 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 41,339 | $11.55 | $477.5K | 859,614 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 14,199 | $11.55 | $164.0K | 293,949 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 3,785 | $11.54 | $43.7K | 855,829 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-24 | 2014-11-25 | 3,303 | $11.54 | $38.1K | 746,849 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-21 | 2014-11-25 | 15,499 | $11.00 | $170.5K | 309,448 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-21 | 2014-11-25 | 39,377 | $11.00 | $433.1K | 786,226 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-21 | 2014-11-25 | 45,124 | $11.00 | $496.4K | 900,953 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 3,500 | $9.27 | $32.4K | 30,100 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 30,100 | $9.33 | $280.8K | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-11-07 | 2014-11-10 | 180,564 | $9.00 | $1.63M | 33,600 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-15 | 2014-10-15 | 51,449 | $10.01 | $515.0K | 214,164 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 14,464 | $11.02 | $159.4K | 946,077 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 12,622 | $11.02 | $139.1K | 825,603 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 4,061 | $11.02 | $44.8K | 265,613 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-14 | 2014-10-15 | 4,968 | $11.02 | $54.7K | 324,947 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 4,072 | $12.14 | $49.4K | 329,999 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 246 | $12.00 | $3.0K | 960,541 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 215 | $12.00 | $2.6K | 838,225 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 69 | $12.00 | $828 | 269,674 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 84 | $12.00 | $1.0K | 330 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 11,855 | $12.14 | $143.9K | 960,787 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 10,345 | $12.14 | $125.6K | 838,440 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2014-10-10 | 2014-10-15 | 3,328 | $12.14 | $40.4K | 269,743 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 71,333 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 86,834 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 221,118 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion deriv | 2014-04-22 | 2014-04-22 | 253,384 | — | $0 | 0 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 94,520 | $11.97 | $1.13M | 324,524 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 75,480 | $11.97 | $903.5K | 261,143 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 86,834 | — | $0 | 86,834 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 71,333 | — | $0 | 71,333 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 221,118 | — | $0 | 221,118 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 118,150 | $12.00 | $1.42M | 204,984 | SEC↗ |
| TRIV TriVascular Technologies, | C Conversion | 2014-04-22 | 2014-04-22 | 253,384 | — | $0 | 253,384 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 19,980 | $12.29 | $245.6K | 185,663 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 25,020 | $12.29 | $307.5K | 230,004 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 340,425 | $12.00 | $4.09M | 593,809 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 297,075 | $12.00 | $3.56M | 518,193 | SEC↗ |
| TRIV TriVascular Technologies, | P Buy | 2014-04-22 | 2014-04-22 | 94,350 | $12.00 | $1.13M | 165,683 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 796,114 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 654,002 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 2,323,086 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-11 | 2,027,262 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 145,333 | — | $0 | 223,733 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 450,502 | — | $0 | 695,152 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 516,241 | — | $0 | 796,591 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 96,600 | $12.00 | $1.16M | 273,514 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 78,400 | $12.00 | $940.8K | 223,733 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 244,650 | $12.00 | $2.94M | 695,152 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-11 | 280,350 | $12.00 | $3.36M | 796,591 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-11 | 176,914 | — | $0 | 273,514 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 572,142 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 161,071 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 196,071 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 499,285 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 349,500 | $15.00 | $5.24M | 848,785 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 112,000 | $15.00 | $1.68M | 273,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 138,000 | $15.00 | $2.07M | 334,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | P Buy | 2014-02-04 | 2014-02-04 | 400,500 | $15.00 | $6.01M | 972,642 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 572,142 | — | $0 | 972,642 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 499,285 | — | $0 | 848,785 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 161,071 | — | $0 | 273,071 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 196,071 | — | $0 | 334,071 | SEC↗ |